rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Cancer and chemotherapy
  name:
    name part: Crooke, Stanley T.
  name:
    name part: Prestayko, Archie W.
  name:
    name part: Alder, Nancy A.
  name:
    name part: ScienceDirect (Online service)
  type of resource: text
  genre: bibliography
  genre: Electronic books.
  origin info:
    place:
      place term: enk
    date issued: 1981
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: 1 online resource (xv, 398 pages) : illustrations
  abstract: Cancer and Chemotherapy, Volume III: Antineoplastic Agents is a collection of articles that deals with the treatment of cancer using drugs. The collection describes the various drugs that are used, the therapeutic approaches being taken, and agents that are being developed. Part I is a general review of anti-cancer drugs as regards their action mechanisms, pharmacokinetics, pharmacology, known toxicities, and clinical utility. These drugs include alkylating agents such as mitomycin C and nitrosoureas; plant alkaloids such as maytansine; antibiotics such as anthracyclines; platinum-containing.
  table of contents: Front Cover; Antineoplastic Agents; Copyright Page; Table of Contents; General Preface; Preface to Volume III; Part I: General Reviews; CHAPTER 1. NUCLEOSIDE ANALOGUES; I. INTRODUCTION; II. CYTOSINE ARABINOSIDE; III. 5-AZACYTIDINE; IV. 5-FLUOROURACIL; V. OTHER 5-FLUORO PYRIMIDINES; VI. 3-DEAZAURIDINE; VII. PURINE ANALOGUES; VIII. ARABINOSYL ADENINE; REFERENCES; CHAPTER 2. CYCLOPHOSPHAMIDE AND ANALOGUES; I. INTRODUCTION; II. STRUCTURE AND METABOLISM; III. CLINICAL PHARMACOLOGY; IV. TOXICITIES; V. CLINICAL ACTIVITY AND DOSE SCHEDULES; VI. ANALOGUES; REFERENCES; CHAPTER 3. NITROSOUREAS.
  table of contents: I. introductionii. decomposition and metabolism; iii. mechanism of action; iv. clinical use; v. clinical toxicities; references; chapter 4. mitomycin c-an overview; i. introduction; ii. chemistry; iii. structure-activity relationships; iv. molecular pharmacology; v. pharmacology; vi. clinical effects; vii. conclusions; references; chapter 5. other alkylating agents; i. introduction; ii. mechanism of action; iii. other alkylating agents; iv. conclusions; references; chapter 6. the vinca alkaloids and similar compounds; i. the vinca alkaloids; ii. the podophyllotoxin derivatives.
  table of contents: Iii. maytansinereferences; chapter 7. bleomycin-an overview; i. introduction; ii. chemistry; iii. molecular pharmacology; iv. clinical pharmacology; v. clinical activities; vi. clinical toxicities; vii. conclusions; references; chapter 8. the anthracyclines; i. introduction; ii. chemistry; iii. molecular pharmacology; iv. clinical pharmacology; v. clinical activities of adriamycin and daunorubicin; vi. toxicities of adriamycin; vii. anthracyclines in development; references; chapter 9. cisplatin and analogues: a new class of anticancer drugs; i. introduction.
  table of contents: Ii. antitumor activity in animal tumorsiii. animal toxicology; iv. efficacy; v. toxicity; vi. cisplatin analogues; vii. conclusion; references; chapter 10. investigational cancer drugs; i. introduction; ii. alkylating agents; iii. anthracycline analogues; iv. tubulin binding agents; v. antitumor antibiotics; vi. nitrosoureas; vii. antimetabolites; viii. miscellaneous; ix. summary; references; chapter 11. hormone therapy; i. basis of endocrine therapy; ii. prostatic cancer; iii. breast cancer; iv. cancer of the uterine endometrium; v. lymphomas; vi. summary; references.
  table of contents: CHAPTER 12. A HUMAN TUMOR STEM CELL SYSTEM: CONCEPTS, METHODOLOGY, AND APPLICATIONI. INTRODUCTION; II. METHODOLOGY; III. APPLICATIONS; IV. CONCLUSIONS; REFERENCES; Part II: Molecular Pharmacology of Selected Antineoplastic Agents; CHAPTER 13. THE MOLECULAR PHARMACOLOGY OF BLEOMYCIN; I. INTRODUCTION; II. CHEMISTRY; III. THE INTERACTIONS OF METALS WITH BLEOMYCIN AND ANALOGUES; IV. EFFECTS OF BLEOMYCIN ON ISOLATED DNA; V. CELLULAR EFFECTS; VI. EFFECTS ON THE CELL CYCLE; VIL MORPHOLOGICAL EFFECTS; Vili. INTRACELLULAR FATE AND METABOLISM; IX. CONCLUSIONS; REFERENCES.
  note: edited by Stanley T. Crooke, Archie W. Prestayko, editorial assistant Nancy Alder.
  note: Includes bibliographical references and index.
  subject:
    topic: Cancer
    topic: Chemotherapy
  subject:
    topic: Cancer
    topic: Chimiothérapie
  subject:
    topic: Cancer
    topic: Chemotherapy
  classification: RC271.C5
  classification: 616.99/4061
  related item:
    title info:
      title: Cancer and chemotherapy
    identifier: (DLC) 79008536
    identifier: (OCoLC)877032671
  identifier: 9781483267913
  identifier: 1483267911
  identifier: 0121978036
  identifier: 9780121978037
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: OPELS
    record creation date: 140627
    record change date: 20260326205322.7
    record identifier: in00005755107
    language of cataloging:
      language term: eng